Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HealthSouth moves forward, restructures management team

This article was originally published in Clinica

Executive Summary

Healthcare services provider HealthSouth has made more management changes. The former chief executive of US Can Co, John Workman, has been named CFO, effective September 20. Mr Workman replaces acting CFO Guy Sansone. Lee Higdon and John Maupin have been elected to the Birmingham, Alabama-based firm's board of directors, and to the special committee of its board, effective immediately. Patrick Foster, president of HealthSouth's inpatient rehabilitation hospital division, and Larry Taylor, president of HealthSouth's surgery division, have both announced their resignations. Mr Foster joined the company in December 1993, and Mr Taylor in May 1987. Additionally, John Chamberlin, director of the board, has also resigned, effective immediately.

You may also be interested in...

Sandoz Denosumab Biosimilar Progressing Faster Than Anticipated

Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.

Dr Reddy's Adds To OTC Portfolio With Glenmark Deal

Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.

Sandoz Launches US Awareness Campaign

Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts